Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ligand Promacta data should support approval, says Roth Capital
Ligand Promacta data should support approval, says Roth Capital
Ligand Promacta data should support approval, says Roth Capital
Submitted by
admin
on June 16, 2014 - 10:04am
Source:
Yahoo/The Fly on the Wall
News Tags:
Ligand Pharmaceuticals
GSK
Promacta
thrombocytopenia
Headline:
Ligand Promacta data should support approval, says Roth Capital
Do Not Allow Advertisers to Use My Personal information
